Drugs that contain Desloratadine; Pseudoephedrine Sulfate
1. Clarinex D 24 Hour patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7214683 | ORGANON | Compositions of descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
| US7214684 | ORGANON | Methods for the treatment of allergic rhinitis |
Dec, 2014
(9 years ago) | |
|
US7214683 (Pediatric) | ORGANON | Compositions of descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
|
US7214684 (Pediatric) | ORGANON | Methods for the treatment of allergic rhinitis |
Jun, 2015
(8 years ago) | |
| US6100274 | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jul, 2019
(4 years ago) | |
|
US6100274 (Pediatric) | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jan, 2020
(4 years ago) | |
| US7618649 | ORGANON | Extended release oral dosage composition |
Dec, 2020
(3 years ago) | |
|
US7618649 (Pediatric) | ORGANON | Extended release oral dosage composition |
Jun, 2021
(2 years ago) | |
| US6979463 | ORGANON | Stable extended release oral dosage composition |
Mar, 2022
(2 years ago) | |
| US7820199 | ORGANON | Stable extended release oral dosage composition |
Mar, 2022
(2 years ago) | |
|
US7820199 (Pediatric) | ORGANON | Stable extended release oral dosage composition |
Sep, 2022
(1 year, 6 months ago) | |
Market Authorisation Date: 03 March, 2005
Treatment: Treatment of allergic rhinitis; A method of treating nasal and non-nasal symptoms of seasonal allergic rhinitis
Dosage: TABLET, EXTENDED RELEASE;ORAL
CLARINEX D 24 HOUR family patents
2. Clarinex-d 12 Hour patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7214683 | ORGANON LLC | Compositions of descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
| US7214684 | ORGANON LLC | Methods for the treatment of allergic rhinitis |
Dec, 2014
(9 years ago) | |
|
US7214684 (Pediatric) | ORGANON LLC | Methods for the treatment of allergic rhinitis |
Jun, 2015
(8 years ago) | |
|
US7214683 (Pediatric) | ORGANON LLC | Compositions of descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
| US6100274 | ORGANON LLC | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jul, 2019
(4 years ago) | |
|
US6100274 (Pediatric) | ORGANON LLC | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jan, 2020
(4 years ago) | |
| US8187630 | ORGANON LLC | Extended release oral dosage composition |
Dec, 2020
(3 years ago) | |
| US7618649 | ORGANON LLC | Extended release oral dosage composition |
Dec, 2020
(3 years ago) | |
| US6709676 | ORGANON LLC | Extended release oral dosage composition |
Feb, 2021
(3 years ago) | |
|
US7618649 (Pediatric) | ORGANON LLC | Extended release oral dosage composition |
Jun, 2021
(2 years ago) | |
Market Authorisation Date: 01 February, 2006
Treatment: Treatment of allergic rhinitis; A method of treating nasal and non-nasal symptoms of seasonal allergic rhinitis; Allergic rhinitis
Dosage: TABLET, EXTENDED RELEASE;ORAL
CLARINEX-D 12 HOUR family patents